| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 42.88B | 47.54B | 46.07B | 43.14B | 39.37B | 19.78B |
| Gross Profit | 3.32B | 3.49B | 3.32B | 4.28B | 5.53B | 3.22B |
| EBITDA | 3.40B | 3.50B | 4.37B | 4.63B | 5.45B | 3.22B |
| Net Income | -63.08M | 20.13M | 860.81M | 1.86B | 2.61B | 1.65B |
Balance Sheet | ||||||
| Total Assets | 63.26B | 59.84B | 53.84B | 46.10B | 36.80B | 24.21B |
| Cash, Cash Equivalents and Short-Term Investments | 2.76B | 2.26B | 1.25B | 1.40B | 2.37B | 1.19B |
| Total Debt | 35.13B | 30.38B | 26.31B | 20.70B | 16.70B | 10.57B |
| Total Liabilities | 47.62B | 43.96B | 39.36B | 33.51B | 25.69B | 15.94B |
| Stockholders Equity | 12.57B | 12.76B | 12.90B | 12.11B | 10.98B | 8.13B |
Cash Flow | ||||||
| Free Cash Flow | 2.46B | -1.24B | 134.87M | -1.22B | 534.69M | -725.01M |
| Operating Cash Flow | 2.42B | 1.44B | 2.20B | 3.16B | 4.21B | 1.14B |
| Investing Cash Flow | -7.05B | -3.64B | -1.71B | -9.18B | -5.13B | -2.19B |
| Financing Cash Flow | 3.32B | 3.05B | -455.15M | 4.93B | 2.02B | 1.16B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$4.47B | 7.86 | 9.36% | 6.70% | -3.73% | 6.09% | |
62 Neutral | HK$18.81B | 13.61 | 10.43% | 0.98% | -1.43% | 113.67% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | HK$1.30B | 20.16 | 2.46% | 3.52% | -5.29% | -32.47% | |
59 Neutral | HK$1.18B | 16.45 | 3.61% | 2.20% | -8.51% | -68.34% | |
56 Neutral | HK$4.20B | 5.57 | 13.87% | ― | 9.20% | 213.87% | |
54 Neutral | HK$10.11B | -142.77 | -0.52% | 1.16% | -15.17% | -125.24% |
China Risun Group Ltd. has announced a provision of a guarantee in connection with a financing arrangement for its joint venture, Risun Wei Shan. The company, holding a 51% stake in the joint venture, has committed to guarantee up to US$269.6 million, aligning with its proportionate equity interest. This move facilitates a US$453 million financing package aimed at refinancing Risun Wei Shan’s existing debts and supporting its working capital needs. While the guarantee showcases the company’s financial commitment to its collaborative projects, it also heightens its financial exposure, which stakeholders will monitor closely.
The most recent analyst rating on (HK:1907) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on China Risun Group Ltd. stock, see the HK:1907 Stock Forecast page.
China Risun Group Limited has announced the termination of a proposed transaction involving the disposal of equity interests in Cangzhou Risun Chemicals Limited in exchange for shares from Tianjin Binhai Energy & Development Co., Ltd. The termination, agreed upon by all parties involved, is not expected to adversely affect Risun Group’s business operations or financial standing. The company remains open to future strategic collaborations with Binhai Energy, indicating ongoing efforts to strengthen its industry positioning.
The most recent analyst rating on (HK:1907) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on China Risun Group Ltd. stock, see the HK:1907 Stock Forecast page.
China Risun Group Ltd. announced the disposal of its 100% equity interest in a subsidiary to Xuyang New Energy for RMB54,686,200. This transaction, classified as a connected transaction due to the involvement of the company’s controlling shareholder, does not require independent shareholders’ approval. The sale aligns with the company’s strategic adjustments, impacting its financial consolidation and potentially altering its market positioning.
The most recent analyst rating on (HK:1907) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on China Risun Group Ltd. stock, see the HK:1907 Stock Forecast page.